Backs FY24 revenue view $400B-$403B, consensus $399.08B. The company said, “UnitedHealth Group affirmed the 2024 performance objectives established at its November 29th Investor Conference, excluding the potential impacts from the pending sale of its Brazil operations, which is expected to close in the first half of 2024. Upon closing, the Company’s net earnings outlook will be impacted by the previously announced expected charge and the Company confirmed the adjusted earnings outlook presented at its Investor Conference.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on UNH:
- UNH Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Options Volatility and Implied Earnings Moves This Week, January 08 – January 12, 2024
- Most Anticipated Earnings This Week – January 8, 2024
- UnitedHealth price target raised to $640 from $610 at Truist
- Unusually active option classes on open January 3rd
